NasdaqGM - Nasdaq Real Time Price USD

GlycoMimetics, Inc. (GLYC)

1.9050 -0.2550 (-11.81%)
As of 2:24 PM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
10.0000
10.0000
75.0000
1,159.7670
10,162.9350
Operating Expense
39,284.6560
39,284.6560
47,477.8790
64,606.9720
61,672.3250
Operating Income
-39,274.6560
-39,274.6560
-47,402.8790
-63,447.2050
-51,509.3900
Net Non Operating Interest Income Expense
2,375.8730
2,375.8730
714.5200
19.7680
482.4870
Pretax Income
-36,898.7830
-36,898.7830
-46,688.3590
-63,427.4370
-51,026.9030
Net Income Common Stockholders
-36,899.4200
-36,899.4200
-46,688.8020
-63,427.4370
-51,026.9030
Diluted NI Available to Com Stockholders
-36,899.4200
-36,899.4200
-46,688.8020
-63,427.4370
-51,026.9030
Basic EPS
-0.58
-0.58
-0.89
-1.23
-1.12
Diluted EPS
-0.58
-0.58
-0.89
-1.23
-1.12
Basic Average Shares
63,342.4650
63,342.4650
52,531.1730
51,453.2940
45,721.1390
Diluted Average Shares
63,342.4650
63,342.4650
52,531.1730
51,453.2940
45,721.1390
Total Operating Income as Reported
-39,275.2930
-39,275.2930
-47,403.3220
-63,447.2050
-51,509.3900
Total Expenses
39,284.6560
39,284.6560
47,477.8790
64,606.9720
61,672.3250
Net Income from Continuing & Discontinued Operation
-36,899.4200
-36,899.4200
-46,688.8020
-63,427.4370
-51,026.9030
Normalized Income
-36,899.4200
-36,899.4200
-46,688.8020
-63,427.4370
-51,026.9030
Interest Income
2,375.8730
2,375.8730
714.5200
19.7680
482.4870
Net Interest Income
2,375.8730
2,375.8730
714.5200
19.7680
482.4870
EBIT
-39,274.6560
-39,274.6560
-47,402.8790
-63,447.2050
-51,509.3900
EBITDA
-39,121.3550
-39,121.3550
-47,195.7340
-63,182.6050
-51,238.6360
Reconciled Depreciation
153.3010
153.3010
207.1450
264.6000
270.7540
Net Income from Continuing Operation Net Minority Interest
-36,899.4200
-36,899.4200
-46,688.8020
-63,427.4370
-51,026.9030
Normalized EBITDA
-39,121.3550
-39,121.3550
-47,195.7340
-63,182.6050
-51,238.6360
12/31/2020 - 1/10/2014
Yahoo Finance Plus Essential access required. Unlock Access

Related Tickers

MRNS Marinus Pharmaceuticals, Inc.
1.4013
-0.62%
 
CTMX CytomX Therapeutics, Inc.
1.6450
-4.91%
 
CDTX Cidara Therapeutics, Inc.
0.7042
-2.47%
 
LPTX Leap Therapeutics, Inc.
2.8340
-4.26%
 
CGTX Cognition Therapeutics, Inc.
1.8700
+1.63%
 
APLM Apollomics, Inc.
0.4730
-7.25%
 
VINC Vincerx Pharma, Inc.
0.8689
-3.46%
 
LYRA Lyra Therapeutics, Inc.
5.26
-2.50%
 
CRVS Corvus Pharmaceuticals, Inc.
1.4100
0.00%
 
PIRS Pieris Pharmaceuticals, Inc.
0.1451
-6.39%